Representative Maria Elvira Salazar has disclosed a purchase of Merck & Co (NYSE: MRK) stock valued between $34,006 and $160,000. According to a filing dated September 9, 2026, the transaction took place on August 19, 2026.
The filing details two separate purchases of Merck & Co stock, each valued between $15,001 and $50,000, executed on the same date. This brings the total disclosed value of the recent acquisition to over $34,000.
Currently, Merck & Co shares are trading at $144.33, representing a decrease of 2.17%.
Representative Salazar’s trading activity over the past three years totals 94 transactions with a combined value exceeding $2.76 million. The largest trades during this period were executed in Biogen and Civitas Resources stock.
In addition to the recent Merck purchases, Representative Salazar sold shares of Chubb (NYSE: CB) valued between $15,001 and $50,000 on August 19, 2026.
Under the STOCK Act, enacted in April 2012, members of Congress are required to file Periodic Transaction Reports to disclose stock purchases and sales within 30 days of notification or 45 days of the transaction date.
